Cai‐Guang Yang

机构：Chinese Academy of Sciences, Shanghai Institute of Materia Medica · ORCID：0000-0001-5778-4422

发表论文 158 篇 · 总被引 10066 次 · h-index 46

代表论文

• Discovery of a potent PROTAC degrader for RNA demethylase FTO as antileukemic therapy (2024 · Acta Pharmaceutica Sinica B · 被引 22)
• Discovery of Covalent and Cell‐Active ALKBH5 Inhibitors with Potent Antileukemia Effects In Vivo (2025 · Angewandte Chemie International Edition · 被引 19)
• Discovery of Novel RNA Demethylase FTO Inhibitors Featuring an Acylhydrazone Scaffold with Potent Antileukemia Activity (2025 · Journal of Medicinal Chemistry · 被引 17)
• Structure-Guided Development of ClpP Agonists with Potent Therapeutic Activities against Staphylococcus aureus Infection (2025 · Journal of Medicinal Chemistry · 被引 13)
• Citrate serves as a signal molecule to modulate carbon metabolism and iron homeostasis in Staphylococcus aureus (2024 · PLoS Pathogens · 被引 13)
• Development of 3-arylaminothiophenic-2-carboxylic acid derivatives as new FTO inhibitors showing potent antileukemia activities (2025 · European Journal of Medicinal Chemistry · 被引 10)